The World’s Only High-Tech Enterprise With Large-Scale D2P Cell-Free Synthetic Protein Production Capability. Our Core Products Hold Disruptive Advantages in Both Cost and Technology.
Scroll
About Us
Healthcode, established in 2015 in Shanghai by Dr. Guo Min, is the world’s only company capable of achieving industrial-scale cell-free protein production at tens of thousands of tons.
Our Technology
Our Advantage
Our Product
Our Commitment
Healthcode Updates & Moments
Our Technology
Healthcode’s D2P Artificial Protein Synthesis Technology (Cell-Free Protein Synthesis, CFPS) enables the rapid synthesis of proteins without the need for living cells, by simulating the transcription–translation process in vitro. By preparing key factors such as ribosomes and enzyme systems, and combining them with exogenous DNA/mRNA templates, amino acids, nucleotides, and energy sources, proteins can be directly synthesized and further processed into concentrated protein nutrient solutions suitable for diverse applications. This technology is fast, efficient, and cost-effective, and—when combined with AI—holds broad potential across healthcare, pharmaceuticals, agriculture, and next-generation biomaterials.
Key Advantages of Cell-Free Protein Expression:
1. Higher Yield: Enables protein synthesis in high-substrate environments, free from cellular constraints, with precise control for greater output. 2. Faster Speed: Produces proteins within hours, far quicker than traditional cell-based methods. 3. Greater Precision: Allows fine control of substrates, temperature, and reaction ratios for high-fidelity, customized proteins. 4. Enhanced Flexibility: Supports adjustable conditions and modifications such as labeling or efficacy testing, making it highly versatile.
Our Product
From agriculture to life, Kangma drives the future with protein innovation. We pioneered the launch of the Light of Desert Agricultural Protein Nutrient Solution, providing cost-effective support for green agriculture, as well as Artificial Hemoglobin, exploring new frontiers in healthcare and life sciences. At the same time, our products also include D2P custom synthesis services, research kits, and functional nutritional proteins. We are building new bridges that connect science with everyday life.
Our Commitment
Healthcode builds sustainable and scalable biomanufacturing platforms, bringing Chinese innovation to the world. Together with our partners, we create value, transform industries, and make the world healthier and better.
Healthcode Updates & Moments
On the afternoon of November 28, 2023, Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the Central Military Commission, visited the Shanghai Science and Technology Innovation Achievements Exhibition and had a cordial exchange with representatives of scientific researchers (in the second row, second from the right is Dr. Min Guo, Founder and CEO of Healthcode)
Healthcode Updates & Moments
On the afternoon of November 28, 2023, Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the Central Military Commission, visited the Shanghai Science and Technology Innovation Achievements Exhibition and had a cordial exchange with representatives of scientific researchers (in the second row, second from the right is Dr. Min Guo, Founder and CEO of Kangma)
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
About Us
Healthcode, established in 2015 in Shanghai by Dr. Guo Min, is the world’s only company capable of achieving industrial-scale cell-free protein production at tens of thousands of tons.
Our Technology
Healthcode’s D2P Artificial Protein Synthesis Technology (Cell-Free Protein Synthesis, CFPS) enables the rapid synthesis of proteins without the need for living cells, by simulating the transcription–translation process in vitro. By preparing key factors such as ribosomes and enzyme systems, and combining them with exogenous DNA/mRNA templates, amino acids, nucleotides, and energy sources, proteins can be directly synthesized and further processed into concentrated protein nutrient solutions suitable for diverse applications. This technology is fast, efficient, and cost-effective, and—when combined with AI—holds broad potential across healthcare, pharmaceuticals, agriculture, and next-generation biomaterials.
Key Advantages of Cell-Free Protein Expression:
1. Higher Yield: Enables protein synthesis in high-substrate environments, free from cellular constraints, with precise control for greater output. 2. Faster Speed: Produces proteins within hours, far quicker than traditional cell-based methods. 3. Greater Precision: Allows fine control of substrates, temperature, and reaction ratios for high-fidelity, customized proteins. 4. Enhanced Flexibility: Supports adjustable conditions and modifications such as labeling or efficacy testing, making it highly versatile.
Our Product
From agriculture to life, Kangma drives the future with protein innovation. We pioneered the launch of the Light of Desert Agricultural Protein Nutrient Solution, providing cost-effective support for green agriculture, as well as Artificial Hemoglobin, exploring new frontiers in healthcare and life sciences. At the same time, our products also include D2P custom synthesis services, research kits, and functional nutritional proteins. We are building new bridges that connect science with everyday life.
Our Commitment
Healthcode builds sustainable and scalable biomanufacturing platforms, bringing Chinese innovation to the world. Together with our partners, we create value, transform industries, and make the world healthier and better.
Healthcode Updates & Moments
On the afternoon of November 28, 2023, Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the Central Military Commission, visited the Shanghai Science and Technology Innovation Achievements Exhibition and had a cordial exchange with representatives of scientific researchers (in the second row, second from the right is Dr. Min Guo, Founder and CEO of Healthcode)
Healthcode Updates & Moments
On the afternoon of November 28, 2023, Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the Central Military Commission, visited the Shanghai Science and Technology Innovation Achievements Exhibition and had a cordial exchange with representatives of scientific researchers (in the second row, second from the right is Dr. Min Guo, Founder and CEO of Kangma)
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
Healthcode Updates & Moments
Kangma Protein Shanghai Factory: The world's first industrial production line for cell-free protein at the hundred-ton level, with a production capacity of 160 tons per day. This production line is independently developed by Kangma, utilizes DCS control in the production process, and features fully automated production control, representing a disruptive innovation in the field of biological synthesis.
Healthcode Core System
DNA-to-Protein (D2P)
From sequence to function. Healthcode’s D2P system powers protein innovation across therapeutic, agricultural, and synthetic biology use cases.
Targeted Anti-Cancer Therapeutics
The Protein Factory
The Light of Desert
Artificial Hemoglobin
Targeted Anti-Cancer Therapeutics
The Protein Factory
The Light of Desert
Artificial Hemoglobin
Targeted Anti-Cancer Therapeutics
The Protein Factory
The Light of Desert
Artificial Hemoglobin
Targeted Anti-Cancer Therapeutics
The Protein Factory
The Light of Desert
Artificial Hemoglobin
Targeted Anti-Cancer Therapeutics

Supports high-throughput screening and expression of various tumor-targeting proteins. Helps shorten the R&D cycle of new drug candidates and lays the groundwork for personalized cancer treatment. (In development, expected to enter clinical stage soon)

The Protein Factory

A modular cell-free protein synthesis platform designed to meet different research and application needs. It supports fast microscale expression, high-yield production, isotopic labeling, and easy-to-use formats — helping both scientists and non-specialists quickly access functional proteins with high efficiency and low barriers.

Learn More
The Light of Desert

Leveraging synthetic proteins to replace conventional feed sources, enabling cost-effective desert greening and advancing ecological agriculture. Now entering stage of large-scale mass production for future-ready, sustainable farming.

Learn More
Artificial Hemoglobin

Rapid in vitro synthesis of key blood proteins enables hemoglobin-like components for efficient blood replacement. The process ensures sterility, universal compatibility, safety, and industrial scalability. It can be applied in emergency blood transfusions, first aid, wartime transfusions, and the treatment of cardiovascular diseases. This technology supports the reconstruction of life-support systems and extends human life. (Already entered Phase I clinical trial in China)

What We Have Achieved
Test Results
Our core agricultural product is a protein nutrient solution that meets enormous global market demand. Its effectiveness far surpasses traditional chemical, compound, and organic fertilizers, enabling the complete replacement of conventional fertilizers.
30+ provinces & 100+ crops
Comprehensive application of grains, vegetables, fruits, and medicinal materials.
15%–100% yield increase, 1/3+ cost savings
Significant reduction in input costs with remarkable yield improvement
From 0 to 100kg/mu wheat yield
Breakthrough results of wheat experiments in extreme saline-alkali soil.
Wheat yield avg. +10.43%, up to ~40%
Proven in large-scale Henan trials
沙漠之光系列蛋白浓缩营养液
What We Are Doing
Core medical product: Artificial hemoglobin (artificial blood) with disruptive technological advantages.
The world’s only cell-free oxygen-carrying artificial hemoglobin product, which has entered Phase I clinical trials in China.
Provides 10–100 times higher oxygen-carrying capacity, universal blood type, virus-free, immune-free, pollution-free; scalable production and long-term storage.
Not only can it replace human blood donations and greatly reduce transfusion costs, but it can also significantly lower the raw material costs and infection risks of various blood-derived products.
The product is also undergoing anti-aging and life-extension testing.
Technology Powers Sustainable Agriculture & Healthcare
Proteins Nurture the Vitality of All Life
01 Use protein to feed crops
02 Use protein to solidify sand particles, stabilize sand and retain water
03 Use protein to nourish the soil, cultivate plant roots and probiotics, and increase soil organic matter
04 Nitrogen, Phosphorus, and Potassium (NPK) in Proteins
05 Use protein to improve saline-alkali beach land into high-quality soil
06 Use protein to turn deserts into black soil
Healthcode Core Innovation Platform
D2P Lab
We are building a leading platform for protein design and synthesis. D2P Lab integrates proprietary tools to accelerate every step from sequence design to production.
Latest News
See all press releases
2025-09-24 00:00
Healthcode Wins CIIF Award
The only national-level industrial award approved by the State Council of China. As the highest recognition in the country’s industrial sector, the CIIF Award underscores Healthcode’s role as a leader in advancing Chinese industrial technology onto the global stage.
Read more
2025-07-22 00:00
D2P Cell-Free Technology Leads the Way in Skin Protection, PE BEAUTIE pioneers new protein innovation, exploring a new path for "China Smart Manufacturing"
Read more
2022-06-24 00:00
Healthcode Builds World’s Largest In Vitro Synthetic Protein Factory
Read more
See all press releases
Our Position: Contributing to the frontiers of biotechnology
We welcome scientists, engineers, and product leaders to join us. Together, we transform discovery, development, and production with cutting-edge technology.
Join Us
Address
4th Floor, Building 2, No. 1233 Maoyuan Road, Fengxian District, Shanghai, China
Follow Us
©2015-2024 Kangma-Healthcode. All Rights Reserved.
沪ICP备16035181号-1 沪公网安备 31011502012862号